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Abstract
The early identification and prevention of dementia is important for reducing its worldwide
burden and increasing individuals’ quality of life. Although several dementia prediction mod-
els have been developed, there remains a need for a practical and precise model targeted to
middle-aged and Asian populations. Here, we used national Korean health examination data
from adults (331,126 individuals, 40–69 years of age, mean age: 52 years) from 2002–2003
to predict the incidence of dementia after 10 years. We divided the dataset into two cohorts to
develop and validate of our prediction model. Cox proportional hazards models were used to
construct dementia prediction models for the total group and sex-specific subgroups.
Receiver operating characteristics curves, C-statistics, calibration plots, and cumulative haz-
ards were used to validate model performance. Discriminative accuracy as measured by C-
statistics was 0.81 in the total group (95% confidence interval (CI) = 0.81 to 0.82), 0.81 in the
male subgroup (CI = 0.80 to 0.82), and 0.81 in the female subgroup (CI = 0.80 to 0.82). Signif-
icant risk factors for dementia in the total group were age; female sex; underweight; current
hypertension; comorbid psychiatric or neurological disorder; past medical history of cardio-
vascular disease, diabetes mellitus, or hypertension; current smoking; and no exercise. All
identified risk factors were statistically significant in the sex-specific subgroups except for low
body weight and current hypertension in the female subgroup. These results suggest that
public health examination data can be effectively used to predict dementia and facilitate the
early identification of dementia within a middle-aged Asian population.
Introduction
Dementia is a major public health concern within the older population. In 2012, the World
Health Organization (WHO) estimated that 36 million people were living with dementia.
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With demographic changes and longer life expectancies, more than 115 million people are
expected to have dementia by 2050. At this rate, the total cost of the disease will rise from
€515 billion to €16 trillion per year [1]. At the individual level, dementia shortens life
expectancy and decreases quality of life. Dementia is estimated to contribute 11.2% of years
lived with disability among individuals >60 years of age compared with 9.5% for stroke and
5.0% for cardiovascular disease [2].
Research on dementia treatment, including that for Alzheimer’s dementia (AD), has made
remarkable progress, but treatment efficacy is still limited [3]. Thus, the early identification of
individuals at a high risk of dementia and correction of modifiable risk factors are crucial.
About one-third of cases of AD, which is the most frequent type of dementia, is attributable to
modifiable risk factors [4]. It is assumed that a 10–25% reduction in modifiable risk factors
could prevent 3 million cases of AD, and delaying the onset of dementia by 1 year could lower
the incidence of dementia by more than 9 million over the next 40 years [5]. There is also a
close relationship between AD and vascular dementia (VD), which is the second most com-
mon type of dementia [6,7]. Epidemiological studies show that AD and VD share common
risk factors such as hypertension, diabetes mellitus, smoking, hypercholesterolemia, and age
[8–10]. Pathological studies also suggest overlap between AD and vascular pathology in older
adults with dementia [11,12]. Therefore, the development of a prediction model for all-cause
dementia, including both AD and VD, could have several practical benefits.
Some existing dementia prediction models use clinic-based criteria to detect mild cognitive
impairment, whereas others use more comprehensively constructed algorithms including
information such as demographic (e.g., age, sex, education) and health-related (e.g., comorbid
diseases, laboratory data, lifestyle information) characteristics [13]. Such models can be
broadly categorized into demographic-only models, cognitive-based models, health risk mod-
els, risk models using genetic information, and multi-variable models [14]. Although predic-
tion models using genetic or neuroimaging data can be particularly informative [15,16], they
are too expensive for primary prevention.
Also, most existing dementia prediction models are designed for an older population >65
years of age. Around 60–70% of aging-related dementia is usually diagnosed after the age of 65
[17], but the disease process may start much earlier. To allow early identification of high-risk
individuals and modification of risk factors, dementia prediction models must be developed
for a mid-life population. Furthermore, few existing prediction models target Asian popula-
tions, especially Koreans. Therefore, we sought to develop a practical and precise dementia
prediction model for a Korean middle-aged population.
In South Korea, the National Health Insurance Service (NHIS) conducts a health examina-
tion for all citizens >40 years of age every 2 years. The NHIS stores all health examination data
and national records of medical utilization and prescriptions for billing purposes. For research
purposes, the NHIS constructs the Health Screening Cohort (NHIS-HEALS) dataset through
anonymization [18]. More than 500,000 randomly sampled individuals are included in
NHIS-HEALS, representing 10% of the entire Korean population. The objective of this study
was to develop a dementia prediction model using health examination data from
NHIS-HEALS for middle-aged Koreans.
Materials and methods
Study population and sample selection
We used baseline NHIS-HEALS data from the years 2002 and 2003. As our primary outcome
was the incidence of all-cause dementia, we identified the following medical diagnostic codes
according to the International Classification of Diseases 10th edition (ICD-10): dementia in
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Alzheimer’s disease (F00), vascular dementia (F01), dementia in Pick’s disease (F02), unspeci-
fied dementia (F03), and Alzheimer’s disease (G30). We selected these codes as our target vari-
able and excluded cases with codes for dementia at baseline.
A total of 473,036 individuals (259,259 males and 213,777 females) between the ages of 40
and 69 years with no history of any dementia at baseline were included. We included the fol-
lowing variables in our analysis: age, sex, body mass index (BMI), systolic blood pressure
(SBP), diastolic blood pressure (DBP), fasting blood glucose, past medical history (i.e., cardio-
vascular disease, diabetes, or hypertension), current comorbid psychiatric or neurologic disor-
ders, current smoking, and exercise. After reviewing previous studies on risk factors for
dementia, these variables were chosen by expert psychiatrists (SK An, K Namkoong, and E
Lee). Explanatory variables, including height, weight, SBP, and DBP, were obtained directly
from the health examination. Other variables, including age, medical history, smoking, and
exercise, were obtained from questionnaires administered during the health examination. BMI
was calculated as weight in kilograms divided by the square of height in meters. In addition,
we obtained information on comorbid psychiatric or neurologic diseases in NHIS-HEALS at
baseline. We excluded individuals with a diagnosis of dementia at baseline or who died within
the first 2 years of observation.
For construction of a dementia prediction model, we divided the baseline data into two data-
sets: a development (70%) and a validation (30%) dataset. The development dataset was used to
fit the parameters of classifiers to establish a prediction model. Validation datasets were used to
assess the accuracy of the final model. We used simple random sampling to divide the two data-
sets regardless of the occurrence of dementia (Fig 1). For missing data, the mean imputation
was used for the whole study sample at every time they gathered by using SAS MI (multiple
imputation) procedure [19]. This study was approved by the Institutional Review Board of the
National Cancer Center, Korea (IRB No. 4-2016-0383). The need for participant consent was
waived by the ethics committee because this study involved routinely collected medical data
that were anonymously managed at all stages, including data cleaning and statistical analysis.
Statistical analysis and prediction model development
The primary outcome of this study was the incidence of all-cause dementia including dementia
in Alzheimer’s disease (F00), vascular dementia (F01), dementia in Pick’s disease (F02),
Fig 1. Flowchart of cohort data processing.
https://doi.org/10.1371/journal.pone.0211957.g001
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unspecified dementia (F03), or Alzheimer’s disease (G30). We defined this event as occurring
when an individual was first diagnosed with dementia corresponding to an ICD-10 code. We
followed individuals from the first health examination date during the baseline period (2002–
2003) until December 31, 2013. The time to event was defined as the time from the first exami-
nation date to the diagnosis date. If an individual was not diagnosed with dementia during the
follow-up period, the time to event was defined as the time from the first examination date to
the most recent date among the last health examination date, the last hospital visit date, and
the date of death. Cases of loss to follow up or death without a dementia diagnosis were consid-
ered as cases without a dementia event, and were censored.
Cox proportional hazards models were used to construct the total and sex-specific sub-
group models using baseline data. The time to event was 10.24 ± 1.73 years (mean ± standard
deviation) in the total group, 10.26 ± 1.78 years in the male subgroup, and 10.21 ± 1.66 years
in the female subgroup in the development cohort and 10.23 ± 1.73 years in the total group,
10.26 ± 1.79 years in the male subgroup, and 10.20 ± 1.67 years in the female subgroup in the
validation cohort.
Explanatory variables included age (5 years), sex (male or female), BMI (underweight:
BMI < 18.5, normal: 18.5 � BMI < 23, overweight: 23 � BMI < 25, obese: BMI � 25 hyper-
tension (normotensive: SBP < 120mmHg and DBP < 80mmHg, prehypertensive:
120mmHg � SBP < 140mmHg and 80mmHg � DBP < 90mmHg, hypertensive I:
140mmHg � SBP < 160 mmHg and 90 mmHg � DBP < 100 mmHg, hypertensive II:
SBP � 160 mmHg and DBP � 100 mmHg), current smoking status (currently smoking or
has smoked >100 cigarettes in their life), regular exercise (>30 minutes a week), past medi-
cal history (cardiovascular disease, diabetes mellitus, or hypertension), and comorbid psy-
chiatric or neurologic disorders. Comorbid psychiatric disorders included the following
diagnoses: organic amnesic syndrome not induced by alcohol or other psychoactive sub-
stances (F04), delirium not induced by alcohol or other psychoactive substances (F05);
other mental disorders due to brain damage and dysfunction or to physical disease (F06);
personality and behavioral disorders due to brain disease, damage, or dysfunction (F07);
unspecified organic or symptomatic mental disorders (F09); schizophrenia, schizotypal, or
delusional disorders (F2x); mood (affective) disorders (F3x); mental retardation (F7x); and
disorders of psychological development (F8x). Neurologic disorders included the following
diagnoses: inflammatory diseases of the central nervous system (G0x), systemic atrophies
primarily affecting the central nervous system (G1x), extrapyramidal and movement disor-
ders (G2x), other degenerative diseases of the nervous system not elsewhere classified
(G31), other degenerative disorders of the nervous system in diseases classified elsewhere
(G32), multiple sclerosis (G35), other acute disseminated demyelination (G36), other demy-
elinating diseases of the central nervous system (G37), and episodic and paroxysmal disor-
ders (G4x).
Cases with missing variables were included in analysis using the fully conditional specifica-
tion (FCS) method, a multiple imputation algorithm, to compensate for the missing values.
Because the FCS approach imputes data on a variable-by-variable basis by specifying an impu-
tation model per variable, this allows tremendous flexibility in creating multivariate models.
To develop the dementia prediction model, Cox proportional hazards regression was per-
formed to analyze the onset of dementia. The probability of dementia (P) at t years for an indi-
vidual with K risk factors was estimated as follows:
P ¼ 1   SðtÞexpðf ½x;M�Þ f ðx:MÞ ¼ b1ðx1   M1Þ þ . . . . . .þ b0ðxp   MpÞ;
where SðtÞ is the survival rate at the mean value of the risk factor at 10 years, b1 � � � � � � bp are
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the regression coefficients, x1 � � � � � � xp represent an individual’s risk factors at baseline, and
M1 � � � � � �Mp are the mean values of the risk factors in NHIS-HEALS.
To validate the dementia prediction model, we evaluated model performance by measur-
ing its ability to discriminate between event and non-event cases using receiver operating
characteristic (ROC) curves, C-statistics, calibration plots, and cumulative hazards. ROC
curves and C-statistics were used to evaluate the ability of the model to predict a binary out-
come [20]. We performed discrimination analysis of the model to assess its performance.
We also used bootstrap method for the calculation of area under the cover (AUC) to esti-
mate corresponding confidence intervals. Calibration plot is a method about the estimated
probabilities and meant to present how well the classifier is calibrated [21]. In this study, it
was used to determine the similarity of the actual target variable to the predicted variable
[22]. Hosmer-Lemeshow (H-L) tests were used for calibration, which was performed by
splitting the observations into five equal-sized risk groups and comparing the observed pro-
portions of event outcomes to the mean predicted proportions of events within each group
[23]. Lastly, we calculated cumulative hazards for the five risk groups divided by their pre-
diction probabilities. All statistical analyses were performed using SAS 9.4 (SAS Institute,
North Carolina, USA) and R version 3.4 (The R Foundation for Statistical Computing,
Vienna, Austria).
Results
Table 1 shows baseline characteristics of the development cohort from NHIS-HEALS (40–69
years of age), including the total group and sex-specific subgroups. Of the total 331,126 indi-
viduals (181,500 males and 149,626 females) in the development cohort, 15,501 (6,664 males
and 8,837 females) were diagnosed with dementia, with an event rate of 4.7% (3.7% for males
and 6.0% for females) during 10 years of follow up (S1 Table). Baseline characteristics of the
validation cohort, including the total group and sex-specific subgroups, are shown in S2 Table.
All characteristics exhibited significant sex differences in both the development and validation
cohorts.
We calculated hazard ratios for dementia for the total group (Table 2) and sex-specific sub-
groups (S3 Table) to construct prediction models using Cox proportional hazards regression
analysis. ROC curves for the total group and sex-specific subgroups are presented in Fig 2. Dis-
criminative accuracy measured by C-statistics was 0.81 for the total group (95% confidence
interval (CI) = 0.81 to 0.82), 0.81 for the male subgroup (CI = 0.80 to 0.82), and 0.81 in the
female subgroup (CI = 0.80 to 0.82). Further discrimination analyses can be seen in S4 Table.
Concordance measured by AUC of 1000 times of bootstrap-estimated value was 0.81 for the
total group (CI = 0.81 to 0.81), 0.81 for the male subgroup (CI = 0.81 to 0.81), 0.81 for the
female subgroup (CI = 0.81 to 0.81). H-L tests for the calibration plots were performed for the
total group and sex-specific subgroups (S1 and S2 Figs). We also calculated cumulative hazard
ratios for five risk groups (S3 Fig).
Our prediction model identified the following risk factors for dementia in the total group:
age; female sex; underweight (BMI < 18.5); current hypertension (SBP� 120 mmHg and
DBP� 80 mmHg); any comorbid psychiatric or neurological disorder; any past medical his-
tory of cardiovascular disease, diabetes mellitus, or hypertension; current smoking; and no
exercise (Fig 3). In the male subgroup, all identified risk factors in the total group analysis were
statistically significant (S4 Fig). Although the hazard ratios in the female subgroup were similar
to those in the total and male subgroups, underweight and current hypertension did not reach
statistical significance (S4 Fig).
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Discussion
We used national health examination data from Korean individuals aged 40–69 years to pre-
dict the development of dementia over 10 years. Using a development cohort, we successfully
constructed a dementia prediction model with a good discrimination index comparable to
that in some previous cohort studies [24–26]. In addition, with a validation cohort, we vali-
dated our prediction model using ROC curves, C-statistics, calibration plots, and cumulative
hazards, the results of which demonstrate good performance of the model.
The discriminative accuracy of our model was constructed from health examination data
obtained by simple laboratory tests, self-report questionnaires, and brief interviews. This good
discriminative accuracy of our model is comparable to or better than that of other multi-vari-
able or demographic data-only dementia prediction models that have discriminative accura-
cies ranging from 0.49 to 0.89 [14]. Therefore, in terms of balancing discriminative accuracy
and efficiency of data collection [27], the present model may be desirable for the early detec-
tion of high-risk individuals. The finding of this study can be used for patient education about
future dementia risk, especially middle-aged individuals who have several risk factors which
found related to dementia occurrence.
Our cohort was consisted of middle-aged individuals from South Korea, who were expected
to undergo a health examination every 2 years. Thus, this cohort represents the characteristics
of the total population of middle-aged Koreans. Population-based studies have several advan-
tages [28]. In addition to providing prevalence rates of relevant variables in the reference








Duration of follow up, years 10.37 ± 1.54 10.39 ± 1.60 10.35 ± 1.46 <0.0001
Age, years 51.41 ± 8.13 50.84 ± 8.03 52.11 ± 8.21 <0.0001
BMI, n (%) Underweight (<18.5) 6,554 (1.98) 3,585 (1.98) 2.969 (1.98) <0.0001
Normal (18.5� n < 23) 115,736 (34.95) 60,069 (33.10) 55,667 (37.32) <0.0001
Overweight (23� n < 25) 90,804 (27.42) 51,569 (28.41) 39,235 (26.22) <0.0001
Obese (�25) 118,032 (35.65) 66,277 (36.52) 51,755 (34.59) <0.0001
Hypertension, n (%) Normotensive
(SBP < 120 and DBP < 80)
85,906 (25.94) 36,892 (20.33) 49,014 (32.76) <0.0001
Prehypertensive
(120� SBP < 140 and
80 � DBP < 90)
179,989 (54.36) 104,097 (57.35) 75,892 (50.72) <0.0001
Hypertensive I
(140� SBP < 160 and
90 � DBP < 100)
52,860 (15.96) 32,787 (18.06) 20,073 (13.42) <0.0001
Hypertensive II
(SBP� 160 and DBP� 100)
12,371 (3.74) 7,724 (4.26) 4,647 (3.11) <0.0001
Known past history, n (%) Cardiovascular disease 21,551 (6.51) 10,516 (5.79) 11,035 (7.38) <0.0001
Diabetes mellitus 12,885 (3.89) 7,500 (4.13) 5,385 (3.60) <0.0001
Hypertension 24,386 (7.36) 11,215 (6.18) 13,171 (8.80) <0.0001
Psychiatric disorder, n (%) 10,824 (3.27) 3,655 (2.01) 7,169 (4.79) <0.0001
Neurological disorder, n (%) 28,686 (8.66) 9,639 (5.31) 19.047 (12.73) <0.001
Current smoking, n (%) 81,727 (24.68) 77,295 (42.59) 4,426 (2.96) <0.001
Regular exercise, n (%) 144,431 (43.62) 93,152 (51.32) 51,279 (34.27) <0.001
Dementia event, n (%) 15,501 (4.7) 6,664 (3.7) 8,837 (6.0) <0.001
P-values indicate differences between male and female subgroups. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.
https://doi.org/10.1371/journal.pone.0211957.t001
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population, they allow comparisons with future cross-sectional studies. They are also ideal for
carrying out unbiased evaluations of relationships between variables. Therefore, our model
allows the expansion and application of follow-up studies of populations in Korea or other
countries.
To our knowledge, we are the first to develop a dementia prediction model for Koreans.
Also, this is the first model developed using simple health examination data from Asians,
although two other dementia prediction models already exist for Asians [29,30]. One model
using data from Japanese adults aged 60–79 years reports risk factors similar to those in our
study [30]. However, the primary goal of this Japanese study was to examine the effect of the
APOE allele on dementia onset, which had a very different focus than that of our study. The
other model, which was modified from the one developed for non-Asian people, was found to
work well for Chinese older adults [29]. However, there is still a lack of studies examining
whether dementia prediction models for certain ethnic groups are applicable to other ethnic
groups. In addition, no studies have examined the effect of ethnicity on dementia risk factors.
Another strength of our model is that it targets a middle-aged population. To allow the
early identification and modification of risk factors, it would be optimal to develop a dementia
prediction model for middle-aged people [31]. There are a few comparable multi-variable pre-
diction models targeting middle-aged populations [24,26,31]. All the models were constructed
using data from non-Asian people and had discriminative accuracies between 0.7 and 0.8. One
was a model constructed using level of education, occupational attainment, and APOE status
[31]. The other two were CAIDE risk score models constructed using simple demographic
data and health-related features [24,26]. One CAIDE risk score model identifies age, low edu-
cation, hypertension, hypercholesterolemia, and obesity as predictive of AD [26]. Although
Table 2. Hazard ratios for baseline variables in the development cohort.
Total
(n = 331,126)
Variable Hazard Ratio 95% Cl p-value
Age (5 years) 1.99 1.97–2.02 <0.0001
Sex (ref = males) 1.32 1.27–1.37 <0.0001
BMI
(ref = normal)
Underweight (<18.5) 1.12 1.01–1.24 0.0285
Overweight (23� n < 25) 0.93 0.90–0.97 0.0009




(120� SBP < 140 and
80 � DBP < 90)
1.03 1.02–1.11 0.0084
Hypertensive I
(140� SBP < 160 and
90 � DBP < 100)
1.11 1.06–1.17 <0.0001
Hypertensive II
(SBP� 160 and DBP� 100)
1.18 1.08–1.27 <0.0001
Known past history Cardiovascular disease 1.44 1.38–1.51 <0.0001
Diabetes mellitus 1.53 1.45–1.62 <0.0001
Hypertension 1.12 1.07–1.17 <0.0001
Psychiatric disorder 1.59 1.50–1.69 <0.0001
Neurological disorder 1.40 1.34–1.46 <0.0001
Current smoking 1.16 1.11–1.21 <0.0001
No exercise 1.18 1.14–1.22 <0.0001
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; ref, reference; CI, confidence interval.
https://doi.org/10.1371/journal.pone.0211957.t002
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some of our risk factors, such as age and hypertension, are similar to those in CAIDE risk
score models for middle-aged cohorts, the predictive value of BMI differs among models
[24,26]. In the present study, a BMI < 18.5 was a risk factor, whereas in the original CAIDE
study, a BMI > 30 was predictive of dementia [26]. Furthermore, in the model that predicted
dementia using CAIDE risk scores in a United States middle-aged cohort, obesity was not a
pronounced risk factor [24]. Among dementia prediction studies among older adults (i.e., >65
years of age), some report obesity as a risk factor [32,33], whereas others report a low BMI as a
risk factor [34]. According to a 2016 WHO report [35], average BMI differs between Asia and
the United States or Europe. In the United States, United Kingdom, and Australia, the average
BMI for adults>18 years of age is 28.9 (28.5–29.3), 27.1 (26.6–27.6), and 27.1 (26.8–27.5),
respectively, whereas the average BMI for Korean adults is 23.8 (23.5–24.0). Moreover, the
Asia-Pacific classification of BMI has lower cutoffs for overweight and obese categories com-
pared with the WHO classification [36]. Thus, the low obesity rate in our cohort may have
contributed to no association between obesity and dementia onset. Furthermore, meta-analy-
ses suggest a possibility of a U-shaped relationship between BMI and dementia in middle-aged
populations [37,38]. A recent prospective study conducted in a French cohort shows that rapid
weight loss in people>65 years of age can contribute to the development of dementia as a pre-
clinical change or a result of malnutrition [39]. BMI is considered a modifiable risk factor
Fig 2. ROC curves for dementia prediction model.
https://doi.org/10.1371/journal.pone.0211957.g002
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along with smoking and alcohol drinking. However, further studies are needed to determine
the optimal modification of BMI and to compare the association of BMI with dementia
between different countries. The effects of risk factor modification on the development of
dementia should also be investigated prospectively.
This study has some limitations. First, we did not include measurements of cognitive func-
tion. Although we intended to predict dementia without any measurement of cognitive func-
tion, gathering this information could have allowed us to compare the performance of our
model with that of previous models and to further validate its predictability. Second, we tar-
geted all-cause dementia, not specifically AD or VD. Thus, our prediction model using health
examination data is not appropriate for identifying or predicting risk factors that could con-
tribute to the occurrence of specific dementias. However, AD and VD share several risk fac-
tors, and most cases of dementia involve brain damage with a neurodegenerative or vascular
insult [40]. Therefore, our model could be used for predicting overall dementia without speci-
fying its type. Third, the follow-up period was only 10 years, which is relatively short consider-
ing that our targeted population was middle-aged people. We will continue to follow up this
population and conduct further studies to overcome this limitation.
Conclusions
Our results suggest that the dementia prediction model can be constructed using information
from simple, routine health examinations of middle-aged people and can be used to detect
individuals with a high risk of developing dementia and administer early interventions via life-
style modifications.
Fig 3. Hazard ratios for risk factors in the total group.
https://doi.org/10.1371/journal.pone.0211957.g003
Population-based dementia prediction model
PLOS ONE | https://doi.org/10.1371/journal.pone.0211957 February 12, 2019 9 / 12
Supporting information
S1 Table. Dementia event rate in the development and validation cohorts (7:3).
(DOCX)
S2 Table. Baseline characteristics of the validation cohort.
(DOCX)
S3 Table. Hazard ratios for baseline variables in the development cohort by sex.
(DOCX)
S4 Table. Model performance of dementia prediction.
(DOCX)
S1 Fig. Calibration plot for the total group.
(TIF)
S2 Fig. Calibration plots for sex-specific subgroups.
(TIF)
S3 Fig. Cumulative hazards for risk groups.
(TIF)
S4 Fig. Hazard ratios for risk factors in sex-specific subgroups.
(TIF)
Author Contributions
Conceptualization: Ji Min Sung, Woo Jung Kim, Suk Kyoon An, Eun Lee.
Data curation: Hyuk-Jae Chang.
Formal analysis: Kyung Mee Park, Ji Min Sung, Woo Jung Kim, Suk Kyoon An, Eun Lee.
Funding acquisition: Eun Lee, Hyuk-Jae Chang.
Investigation: Kyung Mee Park, Ji Min Sung.
Methodology: Ji Min Sung, Woo Jung Kim, Kee Namkoong.
Project administration: Woo Jung Kim, Hyuk-Jae Chang.
Software: Ji Min Sung.
Supervision: Suk Kyoon An, Kee Namkoong, Eun Lee, Hyuk-Jae Chang.
Validation: Kyung Mee Park, Ji Min Sung, Woo Jung Kim, Eun Lee.
Visualization: Kyung Mee Park, Ji Min Sung.
Writing – original draft: Kyung Mee Park, Ji Min Sung, Eun Lee.
Writing – review & editing: Kyung Mee Park, Woo Jung Kim, Suk Kyoon An, Kee Nam-
koong, Eun Lee, Hyuk-Jae Chang.
References
1. Ritchie CW, Molinuevo JL, Truyen L, Satlin A, Van der Geyten S, Lovestone S, et al. Development of
interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzhei-
mer’s Dementia (EPAD) project. Lancet Psychiatry. 2016; 3: 179–186. https://doi.org/10.1016/S2215-
0366(15)00454-X PMID: 26683239
Population-based dementia prediction model
PLOS ONE | https://doi.org/10.1371/journal.pone.0211957 February 12, 2019 10 / 12
2. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and
strategies toward intervention. Dialogues Clin Neurosci. 2009; 11: 111–128. PMID: 19585947
3. Szeto JY, Lewis SJ. Current Treatment Options for Alzheimer’s Disease and Parkinson’s Disease
Dementia. Curr Neuropharmacol. 2016; 14: 326–338. https://doi.org/10.2174/
1570159X14666151208112754 PMID: 26644155
4. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s
disease: an analysis of population-based data. Lancet Neurol. 2014; 13: 788–794. https://doi.org/10.
1016/S1474-4422(14)70136-X PMID: 25030513
5. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence.
Lancet Neurol. 2011; 10: 819–828. https://doi.org/10.1016/S1474-4422(11)70072-2 PMID: 21775213
6. Roman GC, Nash DT, Fillit H. Translating current knowledge into dementia prevention. Alzheimer Dis
Assoc Disord. 2012; 26: 295–299. https://doi.org/10.1097/WAD.0b013e31825cbc4b PMID: 22710935
7. Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer’s disease—lessons from
pathology. BMC Med. 2014; 12: 206. https://doi.org/10.1186/s12916-014-0206-2 PMID: 25385447
8. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, choles-
terol, and misfolded proteins. Lancet. 2004; 363: 1139–1146. https://doi.org/10.1016/S0140-6736(04)
15900-X PMID: 15064035
9. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to
cognitive impairment and dementia: a statement for healthcare professionals from the american heart
association/american stroke association. Stroke. 2011; 42: 2672–2713. https://doi.org/10.1161/STR.
0b013e3182299496 PMID: 21778438
10. Meng XF, Yu JT, Wang HF, Tan MS, Wang C, Tan CC, et al. Midlife vascular risk factors and the risk of
Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014; 42: 1295–1310.
https://doi.org/10.3233/JAD-140954 PMID: 25024338
11. Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: the Honolulu
Asia Aging Study Autopsy Study. Ann Neurol. 2011; 70: 774–780. https://doi.org/10.1002/ana.22520
PMID: 22162060
12. Schneider JA, Bennett DA. Where vascular meets neurodegenerative disease. Stroke. 2010; 41:
S144–146. https://doi.org/10.1161/STROKEAHA.110.598326 PMID: 20876491
13. Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C. Dementia risk prediction in the population: are
screening models accurate? Nat Rev Neurol. 2010; 6: 318–326. https://doi.org/10.1038/nrneurol.2010.
54 PMID: 20498679
14. Tang EY, Harrison SL, Errington L, Gordon MF, Visser PJ, Novak G, et al. Current Developments in
Dementia Risk Prediction Modelling: An Updated Systematic Review. PLoS One. 2015; 10: e0136181.
https://doi.org/10.1371/journal.pone.0136181 PMID: 26334524
15. Barnes DE, Covinsky KE, Whitmer RA, Kuller LH, Lopez OL, Yaffe K. Predicting risk of dementia in
older adults: The late-life dementia risk index. Neurology. 2009; 73: 173–179. https://doi.org/10.1212/
WNL.0b013e3181a81636 PMID: 19439724
16. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide anal-
ysis of genetic loci associated with Alzheimer disease. JAMA. 2010; 303: 1832–1840. https://doi.org/
10.1001/jama.2010.574 PMID: 20460622
17. Jack CR Jr., Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of
dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010; 9: 119–128. https://
doi.org/10.1016/S1474-4422(09)70299-6 PMID: 20083042
18. Seong SC, Kim YY, Park SK, Khang YH, Kim HC, Park JH, et al. Cohort profile: the National Health
Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open. 2017; 7:
e016640. https://doi.org/10.1136/bmjopen-2017-016640 PMID: 28947447
19. SAS Institute Inc. SAS/STAT® 14.1 User’s Guide: The MI Procedure [cited 26 Dec 2018]. Database:
User’s Guide [Internet]. Available from: https://support.sas.com/documentation/onlinedoc/stat/141/mi.
pdf.
20. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in
clinical medicine. Clin Chem. 1993; 39: 561–577. PMID: 8472349
21. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clinical
chemistry. 2008; 54: 17–23. https://doi.org/10.1373/clinchem.2007.096529 PMID: 18024533
22. Vuk M, Curk Tz. ROC Curve, Lift Chart and Calibration Plot. Metodoloˇski zvezki. 2006; 3: 89–108.
23. Fenlon C, O’Grady L, Doherty ML, Dunnion J. A discussion of calibration techniques for evaluating
binary and categorical predictive models. Prev Vet Med. 2018; 149: 107–114. https://doi.org/10.1016/j.
prevetmed.2017.11.018 PMID: 29290291
Population-based dementia prediction model
PLOS ONE | https://doi.org/10.1371/journal.pone.0211957 February 12, 2019 11 / 12
24. Exalto LG, Quesenberry CP, Barnes D, Kivipelto M, Biessels GJ, Whitmer RA. Midlife risk score for the
prediction of dementia four decades later. Alzheimers Dement. 2014; 10: 562–570. https://doi.org/10.
1016/j.jalz.2013.05.1772 PMID: 24035147
25. Exalto LG, Biessels GJ, Karter AJ, Huang ES, Katon WJ, Minkoff JR, et al. Risk score for prediction of
10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol.
2013; 1: 183–190. https://doi.org/10.1016/S2213-8587(13)70048-2 PMID: 24622366
26. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the predic-
tion of dementia risk in 20 years among middle aged people: a longitudinal, population-based study.
Lancet Neurol. 2006; 5: 735–741. https://doi.org/10.1016/S1474-4422(06)70537-3 PMID: 16914401
27. Hou XH, Feng L, Zhang C, Cao XP, Tan L, Yu JT. Models for predicting risk of dementia: a systematic
review. J Neurol Neurosurg Psychiatry. 2018. 2018/06/30. doi: https://doi.org/10.1136/jnnp-2018-
318212 PMID: 29954871
28. Szklo M. Population-based cohort studies. Epidemiol Rev. 1998; 20: 81–90. PMID: 9762511
29. Rawtaer I, Feng L, Yuen VH, Li J, Chong MS, Lim WS, et al. A Risk Score for the Prediction of Neuro-
cognitive Disorders among Community-Dwelling Chinese Older Adults. Dement Geriatr Cogn Disord.
2016; 41: 348–358. https://doi.org/10.1159/000447448 PMID: 27433801
30. Ohara T, Ninomiya T, Kubo M, Hirakawa Y, Doi Y, Hata J, et al. Apolipoprotein genotype for prediction
of Alzheimer’s disease in older Japanese: the Hisayama Study. J Am Geriatr Soc. 2011; 59: 1074–
1079. https://doi.org/10.1111/j.1532-5415.2011.03405.x PMID: 21649613
31. Vuoksimaa E, Rinne JO, Lindgren N, Heikkila K, Koskenvuo M, Kaprio J. Middle age self-report risk
score predicts cognitive functioning and dementia in 20–40 years. Alzheimers Dement (Amst). 2016; 4:
118–125.
32. Anstey KJ, Cherbuin N, Herath PM. Development of a new method for assessing global risk of Alzhei-
mer’s disease for use in population health approaches to prevention. Prev Sci. 2013; 14: 411–421.
https://doi.org/10.1007/s11121-012-0313-2 PMID: 23319292
33. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, et al. Vascular risk
factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis
Assoc Disord. 2006; 20: 93–100. https://doi.org/10.1097/01.wad.0000213814.43047.86 PMID:
16772744
34. Barnes DE, Beiser AS, Lee A, Langa KM, Koyama A, Preis SR, et al. Development and validation of a
brief dementia screening indicator for primary care. Alzheimers Dement. 2014; 10: 656–665 e651.
https://doi.org/10.1016/j.jalz.2013.11.006 PMID: 24491321
35. Mean body mass index trends among adults, age-standardized (kg/m2): Estimates by country. World
Health Organization; 2016.
36. Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness,
screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008;
17: 370–374. PMID: 18818155
37. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for
dementia: a meta-analysis of prospective studies. Obes Rev. 2011; 12: e426–437. https://doi.org/10.
1111/j.1467-789X.2010.00825.x PMID: 21348917
38. Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ, et al. Body mass index in
midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women fol-
lowed in longitudinal studies. Alzheimers Dement (Amst). 2017; 8: 165–178.
39. Wagner M, Helmer C, Tzourio C, Berr C, Proust-Lima C, Samieri C. Evaluation of the Concurrent Tra-
jectories of Cardiometabolic Risk Factors in the 14 Years Before Dementia. JAMA Psychiatry. 2018.
2018/07/26. doi: https://doi.org/10.1001/jamapsychiatry.2018.2004 PMID: 30043038
40. Mangialasche F, Kivipelto M, Solomon A, Fratiglioni L. Dementia prevention: current epidemiological
evidence and future perspective. Alzheimers Res Ther. 2012; 4: 6. https://doi.org/10.1186/alzrt104
PMID: 22339927
Population-based dementia prediction model
PLOS ONE | https://doi.org/10.1371/journal.pone.0211957 February 12, 2019 12 / 12
